In this study, we leveraged scRNA-seq to dissect the cellular diversity of gene expression in tumor-infiltrating CD4+ T cells, aiming to inform precision medicine approaches for ovarian cancer treatment. The gene discussed is CD4; the disease is ovarian carcinoma.